e1 id: E109; e2 id: T7; e1 text: a new right-sided ptosis; e2 text: November 20
ground truth: AFTER; prediction: BEFORE

e1 id: E209; e2 id: E117; e1 text: early lesions; e2 text: small foci in the right cerebellum
ground truth: OVERLAP; prediction: AFTER

e1 id: E66; e2 id: E153; e1 text: prednisone; e2 text: last admission
ground truth: OVERLAP; prediction: AFTER

e1 id: E57; e2 id: E55; e1 text: previous baseline creatinine; e2 text: acute renal failure
ground truth: BEFORE; prediction: OVERLAP

e1 id: E187; e2 id: E158; e1 text: creatinine; e2 text: discharge
ground truth: BEFORE; prediction: AFTER

e1 id: E61; e2 id: E187; e1 text: peak creatinine; e2 text: creatinine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E58; e2 id: E55; e1 text: Kayexalate; e2 text: acute renal failure
ground truth: OVERLAP; prediction: AFTER

e1 id: E213; e2 id: E122; e1 text: progressive Acanthamoeba infection; e2 text: fevers
ground truth: BEFORE; prediction: OVERLAP

e1 id: E145; e2 id: E144; e1 text: pain; e2 text: morphine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E146; e2 id: E144; e1 text: air hunger; e2 text: morphine
ground truth: BEFORE; prediction: OVERLAP

e1 id: E156; e2 id: T5; e1 text: hospitalized; e2 text: November 11
ground truth: BEFORE; prediction: OVERLAP

e1 id: E156; e2 id: T4; e1 text: hospitalized; e2 text: September 26
ground truth: AFTER; prediction: OVERLAP

e1 id: E226; e2 id: E152; e1 text: inflammation; e2 text: prednisone
ground truth: BEFORE; prediction: OVERLAP

e1 id: E227; e2 id: E152; e1 text: adrenal insufficiency; e2 text: prednisone
ground truth: BEFORE; prediction: OVERLAP

e1 id: E228; e2 id: T9; e1 text: comfortable; e2 text: December 3
ground truth: BEFORE; prediction: OVERLAP

e1 id: E211; e2 id: E119; e1 text: cyclosporine; e2 text: cerebritis
ground truth: BEFORE; prediction: AFTER

e1 id: E211; e2 id: E118; e1 text: cyclosporine; e2 text: cyclosporine
ground truth: OVERLAP; prediction: AFTER

e1 id: E219; e2 id: E217; e1 text: Pentamidine; e2 text: a family meeting
ground truth: BEFORE; prediction: AFTER

e1 id: E220; e2 id: E217; e1 text: itraconazole; e2 text: a family meeting
ground truth: BEFORE; prediction: AFTER

e1 id: E221; e2 id: E217; e1 text: Levaquin; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E222; e2 id: E217; e1 text: acyclovir; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E223; e2 id: E217; e1 text: GCSF; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E224; e2 id: E217; e1 text: other medications; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E169; e2 id: E167; e1 text: increasing creatinine; e2 text: readmitted
ground truth: BEFORE; prediction: OVERLAP

e1 id: T0; e2 id: E1; e1 text: nine months; e2 text: non-myeloblative stem cell transplant
ground truth: AFTER; prediction: OVERLAP

e1 id: E3; e2 id: E2; e1 text: medication toxicity; e2 text: ARS
ground truth: OVERLAP; prediction: BEFORE

e1 id: E182; e2 id: E47; e1 text: showing; e2 text: re-CT of sinuses
ground truth: OVERLAP; prediction: AFTER

e1 id: E95; e2 id: E87; e1 text: A repeat CMV hypercapture; e2 text: Workup on admission
ground truth: AFTER; prediction: BEFORE

e1 id: E12; e2 id: T12; e1 text: Rituxan; e2 text: November , 2001
ground truth: OVERLAP; prediction: AFTER

e1 id: E143; e2 id: E217; e1 text: aggressive measures of care; e2 text: a family meeting
ground truth: BEFORE; prediction: OVERLAP

e1 id: E207; e2 id: E204; e1 text: Infectious disease consult; e2 text: admission
ground truth: AFTER; prediction: OVERLAP

e1 id: E205; e2 id: T18; e1 text: erythematous nodules over both arms; e2 text: the days
ground truth: OVERLAP; prediction: BEFORE

e1 id: E101; e2 id: E205; e1 text: progressive skin involvement; e2 text: erythematous nodules over both arms
ground truth: OVERLAP; prediction: BEFORE

e1 id: E37; e2 id: E38; e1 text: azithromycin; e2 text: trial of 5-FC
ground truth: BEFORE; prediction: OVERLAP

e1 id: E47; e2 id: E39; e1 text: re-CT of sinuses; e2 text: itraconazole
ground truth: AFTER; prediction: OVERLAP

e1 id: E41; e2 id: E39; e1 text: continued neutropenia; e2 text: itraconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E42; e2 id: E40; e1 text: sulfadiazine; e2 text: voriconazole
ground truth: OVERLAP; prediction: BEFORE

e1 id: E87; e2 id: E87; e1 text: Workup on admission; e2 text: Workup on admission
ground truth: AFTER; prediction: OVERLAP
This relation involves in BBB

e1 id: E92; e2 id: E87; e1 text: Blood and urine cultures; e2 text: Workup on admission
ground truth: AFTER; prediction: OVERLAP
This relation involves in BBB

e1 id: E183; e2 id: E52; e1 text: inability to tolerate; e2 text: valganciclovir maintenance suppression
ground truth: OVERLAP; prediction: BEFORE

e1 id: E53; e2 id: E183; e1 text: increasing ARS; e2 text: inability to tolerate
ground truth: OVERLAP; prediction: BEFORE

e1 id: E127; e2 id: E124; e1 text: a PICC line; e2 text: A single blood culture
ground truth: BEFORE; prediction: AFTER

e1 id: E135; e2 id: E123; e1 text: all above measures; e2 text: maximal antimicrobial therapy
ground truth: OVERLAP; prediction: AFTER

e1 id: E14; e2 id: T13; e1 text: Campath; e2 text: July , 2001
ground truth: AFTER; prediction: OVERLAP

e1 id: E15; e2 id: E14; e1 text: lymphopenia; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E16; e2 id: E14; e1 text: neutropenia; e2 text: Campath
ground truth: OVERLAP; prediction: BEFORE

e1 id: E85; e2 id: E160; e1 text: treatment; e2 text: admitted
ground truth: AFTER; prediction: OVERLAP

e1 id: E6; e2 id: E173; e1 text: cervical lymphadenopathy; e2 text: presented
ground truth: BEFORE; prediction: OVERLAP

e1 id: E174; e2 id: T2; e1 text: did well; e2 text: 1997
ground truth: BEFORE; prediction: AFTER

e1 id: E10; e2 id: T2; e1 text: progressive disease; e2 text: 1997
ground truth: BEFORE; prediction: AFTER

e1 id: E8; e2 id: E7; e1 text: CytaBOM; e2 text: MACE
ground truth: OVERLAP; prediction: AFTER

e1 id: T11; e2 id: E9; e1 text: six cycles; e2 text: fludarabine
ground truth: OVERLAP; prediction: AFTER

e1 id: E9; e2 id: T2; e1 text: fludarabine; e2 text: 1997
ground truth: OVERLAP; prediction: AFTER

e1 id: E102; e2 id: E207; e1 text: voriconazole; e2 text: Infectious disease consult
ground truth: BEFORE; prediction: AFTER

e1 id: E106; e2 id: E204; e1 text: Pentamidine intravenous and nasal washings; e2 text: admission
ground truth: BEFORE; prediction: AFTER

